Recent

% | $
Quotes you view appear here for quick access.

Array BioPharma Inc. Message Board

ronmalenfant 5 posts  |  Last Activity: Jun 5, 2015 11:28 AM Member since: Jul 10, 2001
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Please find a buyer.

    by judisolley Jun 4, 2015 2:41 PM
    ronmalenfant ronmalenfant Jun 5, 2015 11:28 AM Flag

    This was discussed on the last conference call and management candidly answered that no one would be interested in buying TINY.

  • Reply to

    Shelf registration

    by ronmalenfant May 10, 2015 8:41 AM
    ronmalenfant ronmalenfant May 19, 2015 8:13 AM Flag

    "The offering price per share of our common stock less any underwriting commissions or discounts will generally not be less than the net asset value per share of our common stock at the time we make the offering."

    and I don't generally pay $7.00 a gallon for gas but would under the right circumstances.

  • ronmalenfant by ronmalenfant May 10, 2015 8:41 AM Flag

    Offerings
    We may offer, from time to time, up to $10,000,000 of our common stock, preferred stock, subscription rights to purchase shares of our common stock, debt securities, and warrants representing rights to purchase shares of our common stock, preferred stock or debt securities on terms to be determined at the time of the offering and set forth in one or more supplements to this prospectus

    about a 10% dilution? does TINY trade down to $2.50?

  • Reply to

    OPGEN Pricing Tomorrow Night

    by sfvictim Apr 29, 2015 7:55 PM
    ronmalenfant ronmalenfant Apr 30, 2015 8:17 AM Flag

    --Lowered Expectations-- but still a little good news.

    ."OpGen Sets New Price Range on Planned IPO; Sharply Lowers Anticipated Proceeds
    Apr 24, 2015 | a GenomeWeb staff reporter
    NEW YORK (GenomeWeb) – OpGen lowered the price range on its planned initial public offering, resulting in a sharp drop in its anticipated net proceeds.

    In an amended prospectus filed with the US Securities and Exchange Commission on Thursday, the microbial genetics analysis firm said it anticipates offering 2.5 million units in its IPO at between $5.50 and $6.50 per unit, with net proceeds expected at about $12.6 million at the midpoint price of $6 per unit. Each unit consists of one share of OpGen's common stock and one warrant to purchase an additional share.

    If the offering's underwriter, the Maxim Group, exercises its overallotment option in full, net proceeds are estimated to be $14.7 million.

    Earlier this month, OpGen said that it planned to offer 3.75 million shares of its common stock in the IPO at a range of $8 to $10 per share, which would have resulted in net proceeds of about $30.5 million, or $35.2 million if the overallotment option was exercised in full. It filed to go public in March.

  • ronmalenfant ronmalenfant Apr 29, 2015 6:21 PM Flag

    from TINY's latest 10Q.

    "As of December 31, 2014, we valued the remaining potential milestone payments from the sale of BioVex Group, Inc., at $2,564,917. If all the remaining milestone payments were to be paid by Amgen, Inc., we would receive an additional $7,455,438. There can be no assurance as to the timing and how much of this amount we will ultimately realize in the future."

    can't find any mention of possible future royalties. can you? tia

ARRY
7.21+0.15(+2.12%)Jun 30 4:00 PMEDT